Cleared Traditional

N1 TiUltra TCC Implant System (K211109) - FDA 510(k) Clearance

Class II Dental device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K211109 · Nobel Biocare Services AG · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
251d
Days
Class 2
Risk

K211109 is an FDA 510(k) clearance for the N1 TiUltra TCC Implant System. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by Nobel Biocare Services AG (Kloten, CH). The FDA issued a Cleared decision on December 21, 2021 after a review of 251 days - an extended review cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Nobel Biocare Services AG devices

Submission Details

510(k) Number K211109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 14, 2021
Decision Date December 21, 2021
Days to Decision 251 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 127d · This submission: 251d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 304
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K211109.
CORE1 Implant System
K210039 · Cybermed, Inc. · Jan 2022
Jplant
K211978 · Jj Medical Co., Ltd. · Jan 2022
TRI-matrix Implant Line
K203660 · Tri Dental Implants Int. AG · Dec 2021
DESS Dental Implants
K212538 · Terrats Medical SL · Dec 2021
Paltop Narrow Implant
K210117 · Paltop Advanced Dental Solutions, Ltd. · Nov 2021
Alpha Dent Implants Dental Implants System
K210499 · Alpha Dent Implants GmbH · Nov 2021